Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 22, 2015

Study Completion Date

April 22, 2015

Conditions
PharmacokineticsVoriconazole
Interventions
DRUG

Midazolam/Ranitidine/Esomeprazole

Each of the three drugs will be given at 10% of their usual doses for age/weight.

Trial Locations (1)

90027

Children's Hospital Los Angeles, Los Angeles

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital Los Angeles

OTHER

NCT01976078 - Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents | Biotech Hunter | Biotech Hunter